Fox Chase gets three-year no-cost extension as director Fisher departs

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

God did not intend directors of NCI-designated cancer centers to last in their jobs forever.

They move on to become deans, vice deans, associate vice deans and such. Some return to the lab, clinic, classroom, or all three. Others genuinely retire, or retire in place, with emeritus titles and sets of golf clubs. Still others move on to run other cancer centers or take jobs in the industry or nonprofits. A few become NCI directors.

Very few are asked to turn in their company cell phones and laptops, lose email access, and receive immediate assistance with packing their offices. A few days ago, Richard I. Fisher, president, CEO, and director of Fox Chase Cancer Center, was relieved of his duties at the institution he ran since 2013 (The Cancer Letter, Dec. 7, 2012; May 15, 2015).

Temple University Health System, which owns Fox Chase, announced Fisher’s departure on Nov. 24. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Paul Goldberg
Editor & Publisher
Table of Contents

YOU MAY BE INTERESTED IN

By the end of 2022, Toni Monteiro had no fight left in her. She had been battling a rare blood cancer for three years. Her husband had just died. She was at risk of being evicted from her Washington, DC, apartment. Also, her heart was failing. “You’re really under stress,” Monteiro recalls her physician saying. ...

Paul Goldberg
Editor & Publisher

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login